Tag: T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma.

T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma.
T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma.

Glioblastoma multiforme (GBM) is the most typical major malignant braintumor in adults with a dismal prognosis. We beforehand reported that vaccination with heat shock protein peptide complex-96 (HSPPC-96) improves survival in sufferers with newly diagnosed GBM (NCT02122822). Especially for sufferers with a sturdy antitumor immune response after vaccination, a sturdy survival profit will be achieved. Here, we performed […]

Back to top